Publications en collaboration avec des chercheurs de Hospital de Galdakao - Usansolo (14)

2024

  1. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database

    British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755

  2. Incorporating the One Health philosophy into pharmacovigilanc: Pharmacovigilance

    British Journal of Clinical Pharmacology

  3. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

2019

  1. Reply: On the safety of intravenous iron formulations

    Medicina Clinica

2017

  1. Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

    European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164

2016

  1. Evaluación de la causalidad en las comunicaciones de reacciones adversas a medicamentos. Algoritmo del Sistema Español de Farmacovigilancia

    Medicina Clinica, Vol. 147, Núm. 10, pp. 461-464

2015

  1. Adverse reactions to antipsychotics in parkinson disease: An analysis of the Spanish Pharmacovigilance database

    Clinical Neuropharmacology, Vol. 38, Núm. 3, pp. 69-84

2013

  1. Antipsychotics and seizures: Higher risk with atypicals?

    Seizure, Vol. 22, Núm. 2, pp. 141-143

  2. Eosinophilia associated with bupropion

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 4, pp. 532-534

  3. La notificación directa por los pacientes de reacciones adversas a medicamentos en España

    Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 65-71

2012

  1. Severe hypoglycemia associated with levofloxacin in an elderly diabetic inpatient

    European Geriatric Medicine, Vol. 3, Núm. 3, pp. 181-183

2011

  1. Antipsychotic induced symptomatic hyperprolactinemia: Are dopamine agonists safe?

    Psychopharmacology Bulletin, Vol. 44, Núm. 3, pp. 5

2008

  1. Factors predicting hospital readmissions related to adverse drug reactions

    European Journal of Clinical Pharmacology, Vol. 64, Núm. 7, pp. 715-722

2005

  1. Miliary tuberculosis following treatment with adalimumab [2]

    Farmacia Hospitalaria